AFL vs MXCT · P/E 14, rev $4.12B vs rev $16.9M
Aflac Incorporated (AFL) versus MaxCyte Inc (MXCT) — a side-by-side from cached financials, not a winner call.
Aflac Incorporated (AFL) is a insurance - life company listed on US.
MaxCyte Inc (MXCT) is a medical devices company listed on NASDAQ.
Latest reported AFL revenue for 2026-06-30 was $4.12B. Net income was $825.0M. Revenue was down 5.3% from 2026-03-31 to 2026-06-30. AFL currently screens at market cap $60.18B and trailing P/E 13.5.
Latest reported MXCT revenue for 2026-06-30 was $16.9M. Net income was -$13.6M. Revenue was up 75.3% from 2026-03-31 to 2026-06-30. MXCT currently screens at market cap $124.3M.
AFL currently screens at market cap $60.18B and trailing P/E 13.5. MXCT currently screens at market cap $124.3M.
Not investment advice. Open the AFL and MXCT stock pages for the full models.
Not investment advice.